2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Morning Seminar

[MoS14] Morning Seminar 14　Treatment of peripheral T-cell Lymphoma in the era of CD30 antibody ADC

Sat. Feb 19, 2022 7:20 AM - 8:10 AM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Motoko Yamaguchi（Department of Hematological Malignancies, Mie University Graduate School of Medicine）

Sponsored by Takeda Pharmaceutical Company Limited

[MoS14-1] Treatment of peripheral T-cell Lymphoma in the era of CD30 antibody ADC

○Ritsuro Suzuki (Department of Oncology and Hematology, Shimane University Hospital)